Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up

BACKGROUND: Major bleeding and allogeneic transfusion leads to negative outcomes in patients receiving cardiac surgery with cardiopulmonary bypass (CPB). Ulinastatin, a urine trypsin inhibitor, relieves systemic inflammation and improves coagulation profiles with however sparse evidence of its effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peng, Lv, Hong, Qi, Xia, Xiao, Wenjing, Xue, Qinghua, Zhang, Lei, Li, Lihuan, Shi, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226984/
https://www.ncbi.nlm.nih.gov/pubmed/32410683
http://dx.doi.org/10.1186/s13019-020-01144-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226984/
https://www.ncbi.nlm.nih.gov/pubmed/32410683
http://dx.doi.org/10.1186/s13019-020-01144-9

Ejemplares similares